This double-blind placebo controlled pilot trial will test the hypothesis that prazosin, an
alpha-1 adrenergic receptor antagonist, reduced alcohol consumption and alcohol craving in
alcohol dependent individuals without Post Traumatic Stress Disorder (PTSD). The intervention
period is six weeks.
Phase:
Phase 4
Details
Lead Sponsor:
University of Washington
Collaborators:
US Department of Veterans Affairs VA Office of Research and Development